GABPB1 and neoplasm: This was further validated using in vitro and in vivo assays with GABPB1-AS1 overexpression models, resulting in reduced proliferation, migration, and invasion in 786-o and caki-1 renal cell cancer cells and reduced tumor growth in xenograft models [80].